Press release
Asthma and COPD Drugs Market to Surpass USD 87.6 Billion by 2034
Asthma and COPD Drugs Market
Download Full PDF Sample Copy of Market Report @
https://exactitudeconsultancy.com/request-sample/49893
Key Takeaways
• Market Size (2024): USD 59.4 Billion
• Forecast (2034): USD 87.6 Billion
• CAGR (2025-2034): 3.9%
• Primary Drivers: Growing global asthma and COPD burden, adoption of combination inhalers, and emergence of biologics.
• Key Players: GlaxoSmithKline plc (GSK), AstraZeneca plc, Boehringer Ingelheim, Novartis AG, Teva Pharmaceutical Industries Ltd., Merck & Co. Inc., Cipla Ltd., and Sanofi S.A.
Market Story
The Asthma and COPD Drugs Market continues to expand as rising pollution levels, smoking, and urban lifestyle patterns lead to increased respiratory disorders. Together, asthma and COPD affect more than 500 million people globally, representing a significant healthcare burden and opportunity for innovation.
Pharmaceutical advancements are transforming the treatment landscape - from triple-combination inhalers and biologic therapies to AI-enabled smart inhalers that improve adherence and real-time monitoring. Companies are increasingly focusing on monoclonal antibodies such as IL-5, IL-4, and IgE inhibitors, which offer targeted treatment options for severe and refractory cases.
Digitalization of respiratory care through connected inhalers and telemedicine-integrated platforms is further enhancing patient outcomes, reducing hospitalization rates, and optimizing long-term disease management.
Explore Full Report here:
https://exactitudeconsultancy.com/reports/49893/asthma-copd-drugs-market
Market Segmentation
By Drug Class:
• Bronchodilators (Short-Acting and Long-Acting)
• Anti-Inflammatory Drugs (Corticosteroids, Leukotriene Modifiers)
• Monoclonal Antibodies (Biologics)
• Combination Therapies
• Others
•
By Route of Administration:
• Inhalation (Metered Dose Inhalers, Dry Powder Inhalers, Nebulizers)
• Oral
• Injectable
By Distribution Channel:
• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies
By Disease Type:
• Asthma
• Chronic Obstructive Pulmonary Disease (COPD)
By Region:
• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa
Recent Developments
• 2025: AstraZeneca launched a new triple-combination inhaler with AI-based dose-tracking for COPD management.
• 2024: GSK introduced a biologic targeting IL-5 to treat severe eosinophilic asthma.
• 2024: Cipla Ltd. launched India's first Bluetooth-enabled digital inhaler for asthma and COPD patients.
• 2023: Novartis AG received FDA approval for a novel dual-action bronchodilator for COPD maintenance therapy.
Get Your Exclusive Offer with up to 10% Discount :
https://exactitudeconsultancy.com/checkout/?currency=USD&type=single_user_license&report_id=49893
Expert Insight
"The global shift toward smart inhalers, precision biologics, and digital adherence platforms marks a new era in respiratory medicine," said Irfan Tamboli, Business Development Executive at Exactitude Consultancy.
"With technology now bridging patient care and disease management, asthma and COPD treatment is moving beyond control - toward prevention and personalization."
Regional Outlook
• North America dominates the global market with over 38% share, supported by advanced biologic therapy adoption and reimbursement coverage.
• Europe follows closely, emphasizing sustainability in inhaler manufacturing and prescription monitoring programs.
• Asia Pacific is projected to grow fastest (CAGR above 4.8%) due to high pollution levels, increasing healthcare investment, and affordable generic drug availability.
• Latin America & Middle East are emerging regions with strong growth potential through healthcare expansion and awareness campaigns.
Conclusion
The Asthma and COPD Drugs Market is undergoing a major transformation, driven by the convergence of biotechnology, digital health, and smart delivery systems. As the global focus shifts toward personalized respiratory care, the next decade will see enhanced therapeutic outcomes, reduced disease burden, and improved patient quality of life.
This report is also available in the following languages : Japanese (喘息・COPD治療薬市場), Korean (천식 및 만성폐쇄성폐질환(COPD) 치료제 시장), Chinese (哮喘和慢性阻塞性肺病药物市场), French (Marché des médicaments contre l'asthme et la BPCO), German (Markt für Asthma- und COPD-Medikamente), and Italian (Mercato dei farmaci per l'asma e la BPCO), etc.
Request for a sample of this research report at (Use Corporate Mail ID for Quick Response) @
https://exactitudeconsultancy.com/request-sample/49893
Our More Reports:
Facial Rejuvenation Market
https://exactitudeconsultancy.com/reports/49907/facial-rejuvenation-market
Advanced Ophthalmology Technologies Market
https://exactitudeconsultancy.com/reports/49912/advanced-ophthalmology-technologies-market
Aminoglycoside Antibiotics Market
https://exactitudeconsultancy.com/reports/49914/aminoglycoside-antibiotics-market
Anesthesia Co2 Absorbent Market
https://exactitudeconsultancy.com/reports/49916/anesthesia-co2-absorbent-market
About Us
Exactitude Consultancy is a market research & consulting services firm which helps its client to address their most pressing strategic and business challenges. Our market research helps clients to address critical business challenges and also helps make optimized business decisions with our fact-based research insights, market intelligence, and accurate data.
https://bulletin.exactitudeconsultancy.com/
https://www.thehealthanalytics.com/
https://www.analytica.global/
https://www.marketintelligencedata.com/
https://www.marketinsightsreports.com/
https://exactitudeconsultancy.com/
Connect Us:
Irfan Tamboli
PHONE NUMBER +1 (704) 266-3234
EMAIL ADDRESS: sales@exactitudeconsultancy.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Asthma and COPD Drugs Market to Surpass USD 87.6 Billion by 2034 here
News-ID: 4266944 • Views: …
More Releases from Exactitude Consultancy
Healthcare Finance Solutions Market to Surpass USD 240 Billion by 2034
Pune, India, November 2025 - According to the latest report by Exactitude Consultancy, the global Healthcare Finance Solutions Market is expected to grow from approximately USD 143 billion in 2024 to around USD 240 billion by 2034, registering a CAGR of 5.3% during 2025-2034. This growth is driven by the expansion of healthcare infrastructure, digital transformation initiatives, and rising capital expenditure across hospitals, diagnostics, and pharmaceutical sectors.
Download Full PDF Sample…
Wearable Ambulatory Monitoring Devices Market to Reach USD 23.4
Next-Generation Biosensors, Cloud Analytics, and Telehealth Expansion Accelerate Adoption Across Cardiovascular and Chronic Care Applications
Pune, India, November 2025 - According to a recent report by Exactitude Consultancy, the Global Wearable Ambulatory Monitoring Devices Market is valued at USD 12.8 billion in 2024 and is projected to reach USD 23.4 billion by 2034, growing at a CAGR of 6.3% during 2025-2034. The surge in telemedicine usage, expansion of chronic disease management…
Glioblastoma Multiforme Market Projected to Reach USD 5.8 Billion by 2034
The global market for Glioblastoma Multiforme (GBM) is expected to expand significantly over the 2024-2034 period. With a base year value of around US $3.5 billion in 2024, the market is projected to reach about US $5.8 billion by 2034 - implying a compound annual growth rate (CAGR) of approximately 5.2% from 2025 through 2034.
The study covers key treatment modalities, regional dynamics, segment-level detail, competitive landscape, and growth enablers…
Liver Health Supplements Market Poised for Strong Growth Through 2034
The global liver health supplements market is set to expand markedly over the 2024-2034 period, according to the latest analysis by Exactitude Consultancy. With an estimated market size of around US $0.9 billion in 2024, the market is projected to reach about US $1.9 billion by 2034-representing a compound annual growth rate (CAGR) of roughly 6.9%. The report examines growth drivers, market segmentation, regional dynamics, key players, and future opportunities…
More Releases for COPD
Copd Drugs Market Size Analysis by Application, Type, and Region: Forecast to Co …
USA, New Jersey- According to Market Research Intellect, the global Copd Drugs market in the Internet, Communication and Technology category is projected to witness significant growth from 2025 to 2032. Market dynamics, technological advancements, and evolving consumer demand are expected to drive expansion during this period.
Because respiratory problems are becoming more common worldwide, especially among smokers and older populations, the market for COPD medications is expanding steadily. The need…
Chronic Obstructive Pulmonary Disease (COPD) Treatment Market 2024-2030 Growth: …
Growth: Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Insights :
For stakeholders, an optimistic view is shown by the thorough study of the worldwide "Chronic Obstructive Pulmonary Disease (COPD) Treatment market". The research provides specifics on the market's historical and present conditions as well as projected trends and size. Decision-makers may navigate the competitive environment and investment possibilities in the Chronic Obstructive Pulmonary Disease (COPD) Treatment market with the use of…
Chronic Obstructive Pulmonary Disease (COPD) Therapeutics Market - Breathing Sol …
Newark, New Castle, USA - new report, titled Chronic Obstructive Pulmonary Disease (COPD) Therapeutics Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Chronic Obstructive Pulmonary Disease (COPD) Therapeutics market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Chronic Obstructive Pulmonary Disease…
Asthma & COPD Drugs Market - Breathe Freely, Live Fully: Empowering Respiratory …
Newark, New Castle, USA - new report, titled Asthma & COPD Drugs Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Asthma & COPD Drugs market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Asthma & COPD Drugs market. The report offers…
Copd CBD Gummies: Reviews (Shocking Facts) Copd CBD Oil "Ingredients" Pain Relie …
Copd CBD Gummies: With the increasing need for both individual and expert degrees, the stress and also stress are also enhancing. Individuals are using various methods to fight it. However, as a result of much less time for self, it is really hard. Here the natural herbs and supplements have actually discovered their way into our lives. The Copd CBD Oil are instances of super-effective natural supplements. The CBD existing…
Power Harmonica to Cure Chronic Asthma & COPD
Power Harmonica is a free reed wind musical instrument. It is small rectangular shaped musical instrument. It has 48 number of holes which makes it special and different from other harmonica's.
It's a pocket-friendly musical instrument. Power Harmonica is used as a natural treatment for many types of lung disorders and has no side effects. To play Power Harmonica there is no need of having a musical background it can be…
